ReviewClinical practice and epidemiology in mental health : CP & EMH2025
Lifetime Prevalence of Recurrent and Persistent Depression: A Scoping Review of Epidemiological Studies.
Review in Clinical practice and epidemiology in mental health : CP & EMH, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- rTMS for treatment resistant depression - a single center community experience.Frontiers in psychiatry · 2026Article
- Psychosomatics at the threshold: cancer, mood disorders, and the mental pain of death - where precision medicine meets spirituality.Frontiers in psychiatry · 2026Article
- Treatment experiences and preferences of British South Asians living with recurrent depression.PloS one · 2026Article
- Clinical profile of headache attributed to anxiety and depressive disorders: an observational study.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Differing conceptualizations of recurrent and persistent depression in the Diagnostic and Statistical Manual of Mental Disorders (DSM) and International Classification of Diseases (ICD) lead to diagnostic inconsistencies. This scoping review analyzed epidemiological studies on the lifetime prevalence of recurrent and persistent depression in the general population. Methods: Following PRISMA-ScR guidelines, we searched MEDLINE and the Russian Science Citation Index without time or language restrictions. Inclusion criteria were original epidemiological studies of the general population reporting lifetime prevalence of recurrent or persistent depression, using DSM-III/IV/5 or ICD-9/10/11 criteria. Results: Only three studies on recurrent depression were identified - from Switzerland, the USA, and Hungary - showing a consistent lifetime prevalence of 10.3% to 10.5%. In contrast, major depressive disorder had a lifetime prevalence of 1.5 to 2.5 times higher in these studies. Dysthymia and persistent depression showed lifetime prevalences ranging from 1.1% to 6.4% and 1.6% to 18%, respectively. Women represented about two-thirds of cases of both recurrent and persistent depression. Conclusion: The underrepresentation of recurrent depression may stem from the DSM's dominant influence in psychiatric diagnostics. Our findings highlight the need for refined diagnostic criteria and more comprehensive epidemiological studies that separately identify recurrent and persistent depression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.